9-Boc-6-oxa-1,9-diazaspiro[3.6]decane
![9-Boc-6-oxa-1,9-diazaspiro[3.6]decane price.](/CAS/GIF/1250998-87-8.gif)
|
- $1280 - $2970
- Product name: 9-Boc-6-oxa-1,9-diazaspiro[3.6]decane
- CAS: 1250998-87-8
- MF: C12H22N2O3
- MW: 242.31
- EINECS:
- MDL Number:MFCD14581227
- Synonyms:9-Boc-6-oxa-1,9-diazaspiro[3.6]decane;tert-butyl 6-oxa-1,9-diazaspiro[3.6]decane-9-carboxylate;6-Oxa-1,9-diazaspiro[3.6]decane-9-carboxylic acid, 1,1-dimethylethyl ester
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
- Matrix Scientific
- Synthonix
Package
- 1g
- ManufacturerChemenu
- Product numberCM206471
- Product description9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95%
- Packaging1g
- Price$1280
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11315803
- Product description9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95+%
- Packaging1g
- Price$1359
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number124042
- Product description9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95+%
- Packaging1g
- Price$2970
- Updated2021-12-16
- Buy
- ManufacturerSynthonix
- Product numberX14375
- Product description9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95+%
- Packaging1g
- Price$1640
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM206471 | 9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95% | 1g | $1280 | 2021-12-16 | Buy |
| Crysdot | CD11315803 | 9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95+% | 1g | $1359 | 2021-12-16 | Buy |
| Matrix Scientific | 124042 | 9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95+% | 1g | $2970 | 2021-12-16 | Buy |
| Synthonix | X14375 | 9-Boc-6-oxa-1,9-diazaspiro[3.6]decane 95+% | 1g | $1640 | 2021-12-16 | Buy |
Properties
Boiling point :348.2±37.0 °C(Predicted)
Density :1.13±0.1 g/cm3(Predicted)
pka :9.68±0.20(Predicted)
Density :1.13±0.1 g/cm3(Predicted)
pka :9.68±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|